Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration
Cellular Oncology · 2024
DOI: 10.1007/s13402-024-00934-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2024. Verfasst von Chen-Yang Tao und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Cell Movement, Down-Regulation, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Science and Technology Major Project, Shanghai Municipal Key Clinical Specialty. CAMS Innovation Fund for Medical Sciences (CIFMS).
Abstract (Originalsprache)
Purpose
GPX8, which is found in the endoplasmic reticulum lumen, is a member of the Glutathione Peroxidases (GPXs) family. Its role in hepatocellular carcinoma (HCC) is unknown.
Methods
Immunohistochemical staining was used to detect the protein levels of GPX8 in HCC tissue microarrays. A short hairpin RNA lentivirus was used to knock down GPX8, and the main signaling pathways were investigated using transcriptome sequencing and a phosphorylated kinase array. The sphere formation assays, cloning-formation assays and cell migration assays were used to evaluate the stemness and migration ability of HCC cells. Identifying the GPX8-interacting proteins was accomplished through immunoprecipitation and protein mass spectrometry.
Results
The GPX8 protein levels were downregulated in HCC patients. Low expression of GPX8 protein was related to early recurrence and poor prognosis in HCC patients. GPX8 knockdown could enhance the stemness and migration ability of HCC cells. Consistently, Based on transcriptome analysis, multiple signaling pathways that include the PI3K-AKT and signaling pathways that regulate the pluripotency of stem cells, were activated after GPX8 knockdown. The downregulation of GPX8 could increase the expression of the tumor stemness markers KLF4, OCT4, and CD133. The in vivo downregulation of GPX8 could also promote the subcutaneous tumor-forming and migration ability of HCC cells. MK-2206, which is a small-molecule inhibitor of AKT, could reverse the tumor-promoting effects both in vivo and in vitro. We discovered that GPX8 and the 71-kDa heat shock cognate protein (Hsc70) have a direct interaction. The phosphorylation of AKT encouraged the translocation of Hsc70 into the nucleus and the expression of the PI3K p110 subunit, thereby increasing the downregulation of GPX8.
Conclusion
The findings from this study demonstrate the anticancer activity of GPX8 in HCC by inactivating the Hsc70/AKT pathway. The results suggest a possible therapeutic target for HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Shanghai, China.
- Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences, Beijing, China.
- Department of Biochemistry and Molecular, School of Basic Medical Sciences, Fudan University, Shanghai, China.
- Department of Immunology and Pathogenic Biology, School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Shanghai, China. fan.jia@zs-h…
- Research Unit of Liver cancer Recurrence and Metastasis, Chinese Academy of Medical Sciences, Beijing, China. fan.jia@zs-hospital.sh.cn.
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Science and Technology Major Project
- Shanghai Municipal Key Clinical Specialty. CAMS Innovation Fund for Medical Sciences (CIFMS)
- National Key R&D Program of China
- Clinical Research Plan of SHDC
- Shanghai Municipal Health Commission
Zitieren
APA
Tao, C. Y., Wu, X. L., Song, S. S., Tang, Z., Zhou, Y. F., Tian, M. X., Jiang, X. F., Fang, Y., Zhu, G. Q., Huang, R., Qu, W. F., Gao, J., Chu, T. H., Yang, R., Chen, J. F., Zhao, Q. F., Ding, Z. B., Dai, Z., Zhou, J., …, & Fan, J. (2024). Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration. Cellular Oncology. https://doi.org/10.1007/s13402-024-00934-w
Vancouver
Tao CY, Wu XL, Song SS, Tang Z, Zhou YF, Tian MX, et al. Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration. Cellular Oncology. 2024. doi:10.1007/s13402-024-00934-w
BibTeX
@article{Tao2024,
author = {Tao, Chen-Yang and Wu, Xiao-Ling and Song, Shu-Shu and Tang, Zheng and Zhou, Yu-Fu and Tian, Meng-Xin and Jiang, Xi-Fei and Fang, Yuan and Zhu, Gui-Qi and Huang, Run and Qu, Wei-Feng and Gao, Jun and Chu, Tian-Hao and Yang, Rui and Chen, Jia-Feng and Zhao, Qian-Fu and Ding, Zhen-Bin and Dai, Zhi and Zhou, Jian and Liu, Wei-Ren and Shi, Ying-Hong and Fan, Jia},
title = {Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration},
journal = {Cellular Oncology},
year = {2024},
doi = {10.1007/s13402-024-00934-w}
}
EUVIMED